You can buy or sell Agios and other stocks, options, ETFs, and crypto commission-free!
Agios Pharmaceuticals, Inc. Common Stock, also called Agios, is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. Read More It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Stocks making the biggest moves after hours: Agios, Farfetch, Cisco and more
Luxury fashion items sit on display beside tablet devices at the launch of the Farfetch "Store of the Future" pop-up exhibition, at the Design Museum in London, U.K., on Wednesday, April 12, 2017. Check out the companies making headlines after the bell: Shares of Cisco Systems rose more than 2.5% in extended trading Wednesday after the networking hardware company reported better-than-expected fourth quarter results. Cisco reported earnings of 78 cents per share, 1 cent above Wall Street's estimates, and r...
Seeking AlphaMay 15
Agios' ivosidenib successful in late-stage cholangiocarcinoma study
A Phase 3 clinical trial, ClarIDHy, evaluating Agios Pharmaceuticals' (NASDAQ:AGIO) TIBSOVO (ivosidenib) in previously treated patients with IDH1 mutation-positive cholangiocarcinoma met the primary endpoint of progression-free survival (PFS) compared to placebo.
Yahoo FinanceMay 9
Edited Transcript of AGIO earnings conference call or presentation 2-May-19 12:00pm GMT
Q1 2019 Agios Pharmaceuticals Inc Earnings Call Cambridge May 9, 2019 (Thomson StreetEvents) -- Edited Transcript of Agios Pharmaceuticals Inc earnings conference call or presentation Thursday, May 2, 2019 at 12:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Andrew Hirsch Agios Pharmaceuticals, Inc. - CFO & Head of Corporate...
Expected Aug 1, Pre-Market